Status:
COMPLETED
Retrospective Analysis of the Effects of Perioperative Osteoanabolic Treatment on Patients With Spinal (Fusion) Surgery.
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Spinal (Fusion) Surgery
Eligibility:
All Genders
40-100 years
Brief Summary
This study is to review the the effect of PTH on the outcome of spinal fusion surgery by analyzing the procedure with Forsteo (PTH) previously used in the University Hospital Basel and the Endonet Cli...
Detailed Description
Spinal fusion operations have been performed in patients with risk factors related to healing or bony consolidation. A distinction is made between risk factors that can be influenced, such as nicotine...
Eligibility Criteria
Inclusion
- Patients with spinal (fusion) surgery at the Clinic for Spinal Surgery/ University Hospital Basel
- Perioperative osteo-anabolic therapy between January 1st, 2013 and December 31st, 2018.
Exclusion
- Contraindications to PTH therapy
- Patients refusing therapy with PTH
Key Trial Info
Start Date :
July 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05264610
Start Date
July 20 2021
End Date
November 1 2022
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Orthopaedics and Traumatology, University Hospital Basel
Basel, Switzerland, 4031